Nateglinide

CAS 105816-04-4 9 FDA-DMF suppliersSmall Molecule

Overview

Nateglinide is an oral antidiabetic agent that stimulates insulin secretion by binding to sulfonylurea receptors on pancreatic beta cells. It is used to improve glycemic control in adults with type 2 diabetes mellitus.

API suppliers (10)

Suppliers of Nateglinide backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

  • TAPI NL BV1 active DMF
  • TAPI NL BV1 active DMF
  • Unichem Laboratories Ltd.India1 active DMF
  • SYNTHOKEM LABS PRIVATE LTDIndia1 active DMF
  • SYNTHOKEM LABS PRIVATE LTDIndia1 active DMF
  • Unichem Laboratories Ltd.India1 active DMF
  • TAPI NL BV1 active DMF
  • SYNTHOKEM LABS PRIVATE LTDIndia1 active DMF
  • Unichem Laboratories Ltd.India1 active DMF
  • Cipla USA, Inc.USA

Therapeutic areas

DiabetesEndocrinology

Related APIs

Sitagliptin
50 suppliers
Empagliflozin
42 suppliers
Metformin
28 suppliers
Canagliflozin
23 suppliers
Glimepiride
19 suppliers
Repaglinide
18 suppliers
Pioglitazone Hydrochloride
15 suppliers
Semaglutide
48 suppliers

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.

Start free trialBook a demo